Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide- co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies

Published on Mar 28, 2011in Nanoscale Research Letters3.581
· DOI :10.1186/1556-276X-6-260
Vanna Sanna29
Estimated H-index: 29
Anna Maria Roggio11
Estimated H-index: 11
+ 7 AuthorsMario Sechi33
Estimated H-index: 33
(University of Sassari)
Docetaxel (Dtx) chemotherapy is the optional treatment in patients with hormone-refractory metastatic prostate cancer, and Dtx-loaded polymeric nanoparticles (NPs) have the potential to induce durable clinical responses. However, alternative formulations are needed to overcome the serious side effects, also due to the adjuvant used, and to improve the clinical efficacy of the drug. In the present study, two novel biodegradable block-copolymers, poly(lactide-co-caprolactone) (PLA-PCL) and poly (lactide-co-caprolactone-co-glycolide) (PLGA-PCL), were explored for the formulation of Dtx-loaded NPs and compared with PLA- and PLGA-NPs. The nanosystems were prepared by an original nanoprecipitation method, using Pluronic F-127 as surfactant agent, and were characterized in terms of morphology, size distribution, encapsulation efficiency, crystalline structure, and in vitro release. To evaluate the potential anticancer efficacy of a nanoparticulate system, in vitro cytotoxicity studies on human prostate cancer cell line (PC3) were carried out. NPs were found to be of spherical shape with an average diameter in the range of 100 to 200 nm and a unimodal particle size distribution. Dtx was incorporated into the PLGA-PCL NPs with higher (p < 0.05) encapsulation efficiency than that of other polymers. Differential scanning calorimetry suggested that Dtx was molecularly dispersed in the polymeric matrices. In vitro drug release study showed that release profiles of Dtx varied on the bases of characteristics of polymers used for formulation. PLA-PCL and PLGA-PCL drug loaded NPs shared an overlapping release profiles, and are able to release about 90% of drug within 6 h, when compared with PLA- and PLGA-NPs. Moreover, cytotoxicity studies demonstrated advantages of the Dtx-loaded PLGA-PCL NPs over pure Dtx in both time- and concentration-dependent manner. In particular, an increase of 20% of PC3 growth inhibition was determined by PLGA-PCL NPs with respect to free drug after 72 h incubation and at all tested Dtx concentration. In summary, PLGA-PCL copolymer may be considered as an attractive and promising polymeric material for the formulation of Dtx NPs as delivery system for prostate cancer treatment, and can also be pursued as a validated system in a more large context.
📖 Papers frequently viewed together
338 Citations
1,438 Citations
2,264 Citations
#1Yun Luo (SYSU: Sun Yat-sen University)H-Index: 10
#2You Ling (SCUT: South China University of Technology)H-Index: 5
Last. Xin Gao (SYSU: Sun Yat-sen University)H-Index: 4
view all 9 authors...
Abstract Docetaxel (Dtxl) remains the preferred choice of improving the survival of patients with hormone refractory prostate cancer (HRPC), but many patients suffer from modest drug response and significant toxicity. In the present study, we investigated the efficiency of novel Dtxl loaded-[1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-carboxy(polyethylene glycol)]2000 (DSPE-PEG-COOH) stabilized-oleic acid (OA) coated hydroxyapatite (HA) nanoparticles (Dtxl-NPs) and gained insights into the...
67 CitationsSource
#1Fei Yan (THU: Tsinghua University)H-Index: 21
#2Chao Zhang (Peking Union Medical College)H-Index: 12
Last. Laiqiang Huang (THU: Tsinghua University)H-Index: 32
view all 8 authors...
Abstract The aim of this work was to investigate the effect of triblock copolymer poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Docetaxel-loaded nanoparticles were prepared by oil-in-water emulsion/solvent evaporation technique using biodegradable poly(lactic-co-glycolic acid) (PLGA) with or without addition of poloxamer 188, respectively. The resulting nanoparticles were found to be spherical with a rough and porous surface. The nanoparticles had an avera...
168 CitationsSource
#1Eunhye Lee (Gwangju Institute of Science and Technology)H-Index: 21
#2Hyungjun Kim (Gwangju Institute of Science and Technology)H-Index: 7
Last. Sangyong Jon (Gwangju Institute of Science and Technology)H-Index: 35
view all 4 authors...
Abstract The purpose of this study is to evaluate in vivo antitumor efficacy and subacute toxicity of docetaxel (DTX) prodrug comprising a conjugate between DTX and low molecular weight chitosan (LMWC) after oral administration. DTX was covalently attached to LMWC via a cleavable linker so as to be released from LMWC-DTX conjugate in body. In vitro cytotoxicity of LMWC-DTX conjugate was evaluated by MTT assay against two human cancer cell lines, showing similar IC 50 values to the parent DTX. Th...
117 CitationsSource
#1Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
#2Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 67
Last. Michael J. Thun (ACS: American Cancer Society)H-Index: 22
view all 6 authors...
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are standardized by...
8,804 CitationsSource
#1Kwangjae Cho (Emory University)H-Index: 2
#2Xu Wang (Emory University)H-Index: 22
Last. Dong M. Shin (Emory University)H-Index: 91
view all 5 authors...
Cancer nanotherapeutics are rapidly progressing and are being implemented to solve several limitations of conventional drug delivery systems such as nonspecific biodistribution and targeting, lack of water solubility, poor oral bioavailability, and low therapeutic indices. To improve the biodistribution of cancer drugs, nanoparticles have been designed for optimal size and surface characteristics to increase their circulation time in the bloodstream. They are also able to carry their loaded acti...
2,087 CitationsSource
#1Ashish K. Mehta (MSU: Maharaja Sayajirao University of Baroda)H-Index: 1
#2Khushwant S. YadavH-Index: 13
Last. Krutika K. SawantH-Index: 29
view all 3 authors...
The present study was aimed at developing a sustained release formulation of Nimodipine (NIM) nanoparticles using the biodegradable polymers, poly (lactide-co-glycolide) (PLGA 50:50 and 85:15) as carrier. NIM is a widely used calcium channel blocker which has to be administered as an intravenous infusion for a prolonged period of 1-2 weeks in the treatment of cerebral vasospasm. A sustained release biodegradable formulation would serve to replace this conventional therapy of continuous intraveno...
52 CitationsSource
#1Teresa Musumeci (University of Catania)H-Index: 20
#2Cinzia Anna Ventura (UNIME: University of Messina)H-Index: 17
Last. Giovanni Puglisi (University of Catania)H-Index: 59
view all 7 authors...
Abstract This study investigates the potentiality of nanosphere colloidal suspensions as sustained release systems for intravenous administration of docetaxel (DTX). Nanospheres were prepared by solvent displacement method using polylactic acids (PLA) at different molecular weight and polylactic-co-glycolic (PLGA) as biodegradable matrices. The systems were characterized by light scattering analysis for their mean size, size distribution and zeta potential and by scanning electron microscopy (SE...
338 CitationsSource
#1Hanwei Zhang (CAS: Chinese Academy of Sciences)H-Index: 8
#2Wenjin Cui (CAS: Chinese Academy of Sciences)H-Index: 6
Last. Shenguo Wang (CAS: Chinese Academy of Sciences)H-Index: 28
view all 4 authors...
Abstract The tri-component copolymer poly(lactide- co -glycolide- co -caprolactone) (PLGC) was synthesized to prepare nanoparticles by the modified spontaneous emulsification solvent diffusion method (modified-SESD method); and the method was also modified by using the Tween60 instead of poly(vinyl alcohol) (PVA) as dispersing agent. The obtained nanoparticles have spherical shape and good particle distribution with mean size in the range from 100 to 200 nm. The in vitro degradation behaviour of...
55 CitationsSource
#1Catarina Pinto Reis (UC: University of Coimbra)H-Index: 24
#2Ronald J. Neufeld (Queen's University)H-Index: 33
Last. Francisco Veiga (UC: University of Coimbra)H-Index: 70
view all 4 authors...
Abstract Polymeric nanoparticles have been extensively studied as particulate carriers in the pharmaceutical and medical fields, because they show promise as drug delivery systems as a result of their controlled- and sustained-release properties, subcellular size, and biocompatibility with tissue and cells. Several methods to prepare nanoparticles have been developed during the last two decades, classified according to whether the particle formation involves a polymerization reaction or arises f...
924 CitationsSource
#1Zhiping Zhang (NUS: National University of Singapore)H-Index: 16
#2Si-Shen Feng (NUS: National University of Singapore)H-Index: 71
Abstract Paclitaxel is one of the best anticancer drugs, which has excellent therapeutic effects against a wide spectrum of cancers. The formulation of paclitaxel used in its currently clinical administration includes Cremophor EL, which has been found to cause serious side effects. Nanoparticle formulation of paclitaxel may provide an ideal solution for this problem and achieve a sustained chemotherapy. A novel copolymer, poly(lactide)-vitamin E TPGS (PLA-TPGS), was synthesized from lactide and...
195 CitationsSource
Cited By98
#1Julian David Friedl (University of Innsbruck)H-Index: 3
#2Valeria NeleH-Index: 6
Last. Andreas Bernkop-Schnürch (University of Innsbruck)H-Index: 85
view all 4 authors...
#1Ahmed A. G. El-Shahawy (Beni-Suef University)H-Index: 5
#2Noha Elnagar (Beni-Suef University)
Last. S. I. El-Dek (Beni-Suef University)
view all 5 authors...
The nonspecificity of doxorubicin (DOX), as well as its oral bioavailability, is a major obstacle in the clinical setting. This study was based on the change of pH value and designed for the 1st ti...
#1Ahmed Al Saqr (Salman bin Abdulaziz University)H-Index: 1
#2Shahid Ud Din WaniH-Index: 1
Last. Amr S. Abu Lila (Zagazig University)H-Index: 19
view all 6 authors...
Despite decades of research, breast cancer therapy remains a great challenge. Docetaxel is an antimicrotubule agent that is effectively used for the treatment of breast cancer. However, its clinical use is significantly hampered by its low water solubility and systemic toxicity. The current study was designed to prepare docetaxel (DXL)-loaded silk-fibroin-based nanoparticles (SF-NPs) and to screen their potential antitumor activity against breast cancer cell lines. DXL-loaded SF-NPs were prepare...
1 CitationsSource
#1S. Aishah A. Razak (Universiti Sains Malaysia)H-Index: 1
#2Amirah Mohd Gazzali (Universiti Sains Malaysia)H-Index: 5
Last. Habibah A. Wahab (Universiti Sains Malaysia)H-Index: 17
view all 7 authors...
Docetaxel (DCX) is a highly effective chemotherapeutic drug used in the treatment of different types of cancer, including non-small cell lung cancer (NSCLC). The drug is known to have low oral bioavailability due to its low aqueous solubility, poor membrane permeability and susceptibility to hepatic first-pass metabolism. To mitigate these problems, DCX is administered via the intravenous route. Currently, DCX is commercially available as a single vial that contains polysorbate 80 and ethanol to...
5 CitationsSource
#2Mahmoud M. Abd Elwakil (Alexandria University)H-Index: 6
Last. Ahmed O. ElzoghbyH-Index: 29
view all 11 authors...
Abstract Despite the progress in cancer nanotherapeutics, some obstacles still impede the success of nanocarriers and hinder their clinical translation. Low drug loading, premature drug release, off-target toxicity and multi-drug resistance are among the most difficult challenges. Lactoferrin (LF) has demonstrated a great tumor targeting capacity via its high binding affinity to low density lipoprotein (LDL) and transferrin (Tf) receptors overexpressed by various cancer cells. Herein, docetaxel ...
8 CitationsSource
#1Merve ErkisaH-Index: 8
#2Ferda Ari (Uludağ University)H-Index: 17
Last. Engin UlukayaH-Index: 29
view all 7 authors...
Prostate cancer is among the leading causes of death worldwide because its metastatic form is a deadly disease. Therefore, the development of new chemotherapeutics is of immense importance. Nanoparticle technology seems to provide diverse options in this regard. Therefore, poly(N-isopropylacrylamide) (PNIPAM) coated superparamagnetic iron oxide nanoparticles (SPION) loaded with Etoposide were prepared in small sizes (57 nm) and with 3.5 % drug content to improve the efficiency of Etoposide in pr...
1 CitationsSource
#1Mahmood Barani (SBUK: Shahid Bahonar University of Kerman)H-Index: 16
#2Fakhara Sabir (University of Szeged)H-Index: 6
Last. George Z. Kyzas (International Hellenic University)H-Index: 56
view all 5 authors...
The fabrication and development of nanomaterials for the treatment of prostate cancer have gained significant appraisal in recent years. Advancements in synthesis of organic and inorganic nanomaterials with charge, particle size, specified geometry, ligand attachment etc have resulted in greater biocompatibility and active targeting at cancer site. Despite all of the advances made over the years in discovering drugs, methods, and new biomarkers for cancer of the prostate (PCa), PCa remains one o...
20 CitationsSource
#1Mustafa E. Omer (National Guard Health Affairs)H-Index: 3
#2Majed Halwani (National Guard Health Affairs)H-Index: 10
Last. Alaa Eldeen B. Yassin (National Guard Health Affairs)H-Index: 14
view all 9 authors...
Ciprofloxacin (CIP), a widely used antibiotic, is a poor biopharmaceutical resulting in low bioavailability. We optimized a CIP polymer-lipid hybrid nanoparticle (CIP-PLN) delivery system to enhance its biopharmaceutical attributes and the overall therapeutic performance. CIP-PLN formulations were prepared by a direct emulsification-solvent-evaporation method. Varying the type and ratio of lipid was tried to optimize a CIP-PLN formulation. All the prepared formulations were evaluated for their p...